Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Telehealth Digital Health Diabetic Care

Omada Health Panel Outlines Transformative Role Of Digital Health In Rural Areas

  • Analysis

Executive Summary

A panel discussion hosted by Omada health discussed how the experiences of rural communities such as those in Alaska offer insight to the future development of telehealth.

You may also be interested in...



COVID-19 Flexibility For Telehealth Payments Should Be Made Permanent, Telemedicine Group Tells CMS

The American Telemedicine Association backed use of more telehealth providers and changes to remote monitoring reimbursements in comments to the US Medicare agency.

Market Intel: Why Telehealth, Digital Therapies Will Provide Mental Health Support Beyond COVID-19 Crisis

In this second part of a two-part series focusing on mental health tech, Medtech Insight highlights behavioral digital health companies that have attracted investors’ attention. Part one focused on transcranial magnetic stimulation.

Minute Insight: Stimdia Starts Trial Of Phrenic Nerve Stimulator For Patients On Ventilators

Stimdia is trying to restore respiratory function in ICU patients with phrenic nerve stimulation.

Table

View full table

Topics

Tags:
Telehealth Digital Health Diabetic Care
Latest Headlines

Medtech Connect Episode 10: Breaking Down The Transitional Coverage Of Emerging Technologies

Medtronic Hires New Neuromodulation Leader

New ePortal To Simplify Processing & Tracking Of WHO Prequalification Applications

Minute Insight: Stimdia Starts Trial Of Phrenic Nerve Stimulator For Patients On Ventilators

See All
UsernamePublicRestriction

Register

MT145174

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By